Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
International Euro Ewing (iEuroEwing)
DRKS00024200Phase 3Recruiting
- Sponsor
- German Society for Pediatric Oncology and Hematology
- Start
- Apr 2023
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 16
01
Overview
Phase 3, randomised trial of vincristine, doxorubicin, cyclophosphamide, ifosfamide, etoposide and 2 more in Ewing sarcoma, Malignant neoplasm of bone and articular cartilage of limbs and Malignant neoplasm of bone and articular cartilage of other and unspecified sites (4 arms), sponsored by German Society for Pediatric Oncology and Hematology. Started Apr 2023; status: recruiting.
02
Drugs
vincristinedoxorubicincyclophosphamideifosfamideetoposide
03
Conditions
Ewing sarcomaMalignant neoplasm of bone and articular cartilage of limbsMalignant neoplasm of bone and articular cartilage of other and unspecified sites
Beyond the preview
Go deeper on DRKS00024200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00024200.